AVRW Stock Overview
Through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Avenir Wellness Solutions, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.03 |
| 52 Week High | US$0.095 |
| 52 Week Low | US$0.013 |
| Beta | -0.46 |
| 11 Month Change | 16.99% |
| 3 Month Change | 1.00% |
| 1 Year Change | -53.38% |
| 33 Year Change | -93.27% |
| 5 Year Change | -98.97% |
| Change since IPO | -98.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| AVRW | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -25.2% | 2.8% | 2.2% |
| 1Y | -53.4% | 11.8% | 32.6% |
Return vs Industry: AVRW underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.
Return vs Market: AVRW underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| AVRW volatility | |
|---|---|
| AVRW Average Weekly Movement | 44.9% |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AVRW's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AVRW's weekly volatility has increased from 39% to 45% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Nancy Duitch | www.avenirwellness.com |
Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers.
Avenir Wellness Solutions, Inc. Fundamentals Summary
| AVRW fundamental statistics | |
|---|---|
| Market cap | US$2.36m |
| Earnings (TTM) | -US$2.76m |
| Revenue (TTM) | US$2.05m |
1.2x
P/S Ratio-0.9x
P/E RatioIs AVRW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AVRW income statement (TTM) | |
|---|---|
| Revenue | US$2.05m |
| Cost of Revenue | US$608.00k |
| Gross Profit | US$1.44m |
| Other Expenses | US$4.19m |
| Earnings | -US$2.76m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.035 |
| Gross Margin | 70.27% |
| Net Profit Margin | -134.82% |
| Debt/Equity Ratio | -70.6% |
How did AVRW perform over the long term?
See historical performance and comparison